L. K. Gjærde

发表

Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients

R. Agius, J. Lundgren, C. MacPherson, 2022, Communications Medicine.

Ocular Chronic Graft-Versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes After Allogeneic Haematopoietic Cell Transplantation.

H. Sengeløv, H. O. Julian, Steffen Heegaard, 2022, Transplantation and cellular therapy.

Pre-transplantation vitamin E levels and acute graft-versus-host disease after non-myeloablative allogeneic hematopoietic cell transplantation.

H. Sengeløv, N. Jørgensen, S. Ostrowski, 2022, Transplant Immunology.

Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

H. Sengeløv, S. Ostrowski, L. Friis, 2019, Bone Marrow Transplantation.

Pre-Transplantation Plasma ST2 Level as a Prognostic Biomarker of 1-Year Non-Relapse Mortality in Allogeneic Hematopoietic Cell Transplantation.

H. Sengeløv, S. Ostrowski, L. Friis, 2022, Transplantation and cellular therapy.

Hypomethylating agent-based therapies in older adults with acute myeloid leukemia - A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee.

K. Loh, Yue Zhao, Joseph Lombardo, 2022, Journal of geriatric oncology.

Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST): a study from the Transplant Complications Working Party and Nurses Group of the EBMT

D. Greenfield, J. Mooyaart, Z. Perić, 2022, Bone Marrow Transplantation.

Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.

E. Bernasconi, P. Reiss, J. Dufour, 2019, Journal of hepatology.

Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based study

H. Sengeløv, M. Andersen, H. Marquart, 2021, Leukemia & lymphoma.

Fitting parametric cure models in R using the packages cuRe and rstpm2

L. Jakobsen, L. K. Gjærde, Mark Clements, 2022, Comput. Methods Programs Biomed..

Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease

H. Sengeløv, Mette Schmidt, L. K. Gjærde, 2018, Bone Marrow Transplantation.

Cytokine autoantibodies are stable throughout the haematopoietic stem cell transplantation course and are associated with distinct biomarker and blood cell profiles

H. Sengeløv, S. Ostrowski, M. Hansen, 2021, Scientific Reports.

Triple-drug GVHD prophylaxis after HLA-matched unrelated donor non-myeloablative allogenic hematopoietic stem cell transplantation.

H. Sengeløv, L. Friis, N. Andersen, 2023, Transplantation and Cellular Therapy.

Recognising inequalities in haematopoietic stem-cell transplantation and cellular therapy training.

N. Gagelmann, Yasmina Serroukh, L. K. Gjærde, 2022, The Lancet. Haematology.

Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.

E. Bernasconi, P. Reiss, J. Dufour, 2019, Journal of hepatology.

Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation in the Context of CMV Infection

H. Sengeløv, C. MacPherson, S. Brix, 2023, Metabolites.